Neuromodulation and female pelvic disorders

Area of Science:

• Urology
• Gastroenterology
• Neuromodulation

Background:

• Sacral neuromodulation is an FDA-approved therapy for refractory overactive bladder, urinary retention, and fecal incontinence.
• Significant advancements have been made in therapy techniques and long-term outcome data.
• The InSite trial and fecal incontinence registry trial provide supporting evidence.

Purpose of the Study:

• To review recent literature on clinical outcome data for sacral neuromodulation.
• To discuss current management strategies for sacral neuromodulation.
• To highlight advancements in therapy techniques and surgical approaches.

Main Methods:

• Review of recent clinical outcome data.
• Analysis of long-term follow-up studies.
• Discussion of surgical technique improvements and programming advancements.

Main Results:

• Long-term data support sacral neuromodulation for urinary and fecal incontinence.
• Advancements include improved surgical techniques to reduce infection.
• Enhanced programmability of implantable pulse generators and optimized stimulation parameters.

Conclusions:

• Recent data inform clinical outcomes and best practices for sacral neuromodulation.
• Improved techniques and long-term data enhance patient management strategies.
• New animal models pave the way for future research in neuromodulation.